Statute Details
- Title: Medical (Therapy, Education and Research) (Approved Hospitals and Medical Schools) Notification 2010
- Act Code: MTERA1972-N1
- Type: Subsidiary Legislation (SL)
- Authorising Act: Medical (Therapy, Education and Research) Act 1972 (noted in the legislation as “Section 2B”)
- Key Provision: Section 2 (Minister’s declaration of approved hospitals and approved medical schools)
- Current Version: Current version as at 27 Mar 2026 (with a 2025 Revised Edition dated 2 June 2025)
- Most Recent Revision Noted: 2 June 2025 (2025 RevEd)
- Legislative History (selected): Amended by S 575/2010 (11 Oct 2010); S 562/2015 (21 Sep 2015); S 566/2018 (19 Sep 2018); S 412/2024 (15 May 2024)
What Is This Legislation About?
The Medical (Therapy, Education and Research) (Approved Hospitals and Medical Schools) Notification 2010 is a Singapore subsidiary legislation instrument that operates as a formal “approval list” for the Medical (Therapy, Education and Research) Act 1972. In practical terms, it identifies which hospitals and which medical schools are recognised as “approved” for the purposes of the parent Act.
Although the Notification itself is brief, its legal effect can be significant. Many regulatory regimes in healthcare and biomedical research depend on whether an institution is approved under an enabling statute. Once an institution is listed as an approved hospital or approved medical school, it becomes eligible to participate in activities governed by the Medical (Therapy, Education and Research) Act 1972—typically including activities involving therapy, education, and research that the Act regulates.
Accordingly, the Notification should be read alongside the Medical (Therapy, Education and Research) Act 1972. The Notification does not create a standalone compliance framework; rather, it supplies the institutional eligibility component. For practitioners, the key question is not only “what does the Notification say?” but also “what consequences flow from being approved under the Act?”
What Are the Key Provisions?
Section 1 (Citation). Section 1 provides the short title and citation of the Notification. While this is standard drafting, it matters for legal referencing, especially when counsel or compliance teams need to cite the correct instrument in submissions, internal policies, or regulatory correspondence.
Section 2 (Minister’s declaration of approved institutions). Section 2 is the core operative provision. It empowers the Minister to declare two categories of institutions for the purposes of the Medical (Therapy, Education and Research) Act 1972:
- Approved hospitals: Section 2(a) declares the hospitals specified in Part 1 of the Schedule to be “approved hospitals” for the purposes of the Act.
- Approved medical schools: Section 2(b) declares the medical schools specified in Part 2 of the Schedule to be “approved medical schools” for the purposes of the Act.
In plain language, Section 2 is the legal mechanism that turns the Schedule into an authoritative list. The Schedule is therefore not merely descriptive; it is the substantive content that determines which institutions qualify.
The Schedule (the approval lists). The Notification contains a Schedule with at least two parts: Part 1 (approved hospitals) and Part 2 (approved medical schools). The Schedule is where the named institutions appear. For legal practitioners, the Schedule is the “working document” for eligibility. Any change to the Schedule—whether by amendment notification or revised edition—can alter which institutions are covered.
Amendments and version control. The legislative history indicates multiple amendments over time (2010, 2015, 2018, 2024) and a 2025 Revised Edition. This is important because approval status can change: institutions may be added, removed, or reclassified through amendments to the Schedule. Practically, counsel should always confirm the current version “as at” the relevant date for transactions, approvals, ethics submissions, or compliance audits. The Notification itself emphasises that users should check the legislation timeline to ensure they are viewing the correct version.
How Is This Legislation Structured?
The Notification is structured in a simple, functional way:
- Section 1: Citation.
- Section 2: Minister’s declaration—authorising the approval of hospitals and medical schools listed in the Schedule.
- Schedule: The detailed lists, divided into at least two parts:
- Part 1: Hospitals specified as approved hospitals.
- Part 2: Medical schools specified as approved medical schools.
Because the Notification is short, it is best approached as an “eligibility instrument” rather than a comprehensive regulatory code. The real compliance obligations typically arise from the parent Act and any related subsidiary legislation or regulatory guidance made under it.
Who Does This Legislation Apply To?
The Notification applies to institutions—specifically, hospitals and medical schools—that are named in the Schedule as approved for the purposes of the Medical (Therapy, Education and Research) Act 1972. It also indirectly affects persons and entities that interact with those institutions in regulated contexts (for example, researchers, clinicians, sponsors, and institutional governance bodies), because the ability to conduct certain activities under the Act may depend on the institution’s approved status.
In addition, the Notification is directed at the Minister’s exercise of power under the authorising Act. From a legal practice perspective, this means that the approval list is an administrative/legal determination. If an institution’s approval status is challenged or needs to be verified, the Schedule and its amendments become central evidence.
Why Is This Legislation Important?
Even though the Notification is brief, it can be pivotal in healthcare and biomedical research compliance. Many regulated activities require an approved institutional setting. If an institution is not listed as an approved hospital or approved medical school, it may be ineligible to participate in activities that the Medical (Therapy, Education and Research) Act 1972 contemplates for approved institutions. This can affect project planning, contracting, ethics and governance workflows, and timelines for research or therapy-related initiatives.
For practitioners, the Notification is also important because it is a living instrument subject to amendment. The presence of multiple amendments (2010, 2015, 2018, 2024) and a revised edition (2025) signals that approval status is not static. A lawyer advising an institution, a sponsor, or a research team should therefore treat the approval list as a compliance “checkpoint” that must be verified at the relevant time.
Finally, the Notification’s legal significance is amplified by its relationship with the parent Act. Section 2 of the Notification explicitly ties the approvals to “the purposes of the Act.” That linkage means the Notification is not merely administrative; it is a statutory gateway. In practice, counsel should read the Notification together with the Medical (Therapy, Education and Research) Act 1972—particularly the provisions that define what “approved hospitals” and “approved medical schools” can do, and what regulatory consequences follow from approval.
Related Legislation
- Medical (Therapy, Education and Research) Act 1972 (Authorising Act; referenced as including Section 2B in the Notification’s materials)
Source Documents
This article provides an overview of the Medical (Therapy, Education and Research) (Approved Hospitals and Medical Schools) Notification 2010 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.